Search
for
Sort by
Research 301–330 of 1000+
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators
- Prevention of erlotinib-induced folliculitis with doxycycline
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Anticancer Effects of Broccoli Sprout Extract and Sulforaphane Through ROS-Induced MAPK Pathway in Breast Cancer Cells and Xenografts
- Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- LB822 Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in breast cancer cells
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Stem Cells in the Wild: Understanding the World of Stem Cells through Intravital Imaging
- Transient perforating folliculitis induced by sorafenib
- Hypertrichosis of the pinnae in a patient using panitumumab
- Electric Hair Follicular Stimulation
- Testosterone therapy for transgender men
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Dermatological drugs, topical agents, and cosmetics